Skip to main content
Fig. 3 | Translational Medicine Communications

Fig. 3

From: RLS-0071, a dual-targeting anti-inflammatory peptide - biomarker findings from a first in human clinical trial

Fig. 3

A RLS-0071 binding to C1q measured by ELISA-type assay for Cohorts 3 (40 mg/kg), 6 (120 mg/kg), 7 (40 mg/kg Q8hr). Individual subject values are shown as solid symbols. Placebo (open symbol) shows the values of the 6 placebo subjects for those cohorts. B RLS-0071 binding to MPO measured by ELISA-type assay for Cohorts 3 (40 mg/kg), 6 (120 mg/kg), 7 (40 mg/kg Q8hr). Individual subject values are shown as solid symbols. Placebo (open symbol) shows the values of the 6 placebo subjects for those cohorts

Back to article page

Translational Medicine Communications

ISSN: 2396-832X

Contact us